Clinical trial
Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
NCT06306209 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 18, 2021
- Completion date
- January 14, 2025
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.